Silychristin (Silymarin Component B · Hepatoprotective · Antioxidant)

Compound	Silychristin (Silymarin Component B; Silychristin A + B diastereomers)
Chemical class	Polyphenol — Flavonolignan (taxifolin + sinapyl alcohol ether; second-most abundant silymarin component)
CAS	33889-69-9
Primary source	Silybum marianum (milk thistle seeds — ~20% of the silymarin complex)
Key applications	Hepatoprotective; RNA polymerase I activation (liver regeneration); antioxidant; anti-inflammatory
Claim strength	Moderate
Typical form	Organic Milk Thistle Extract Powder (silychristin co-delivered at ~20% of silymarin complex); Silymarin 70-80% extracts
Buy from Herbuno	Organic Milk Thistle (Silybum marianum) Extract Powder → Milk Thistle Seed Liquid Extract (Water Soluble) - Silybum marianum →

Name origin: Silychristin is named after Silybum (milk thistle) and "chrystin" — from the Greek "chrysos" (gold), possibly reflecting the golden-yellow colour of silymarin crystals or the amber colour of silymarin-containing extracts. It is the second-most abundant component of the silymarin complex after silybin, representing approximately 20% of standardised milk thistle extract. Traditional use: Silychristin has no independent traditional use — it is a component of milk thistle seed extract, where the full silymarin complex has been used for liver protection across European, Arabic (Ibn Sina/Avicenna), and North African medicinal traditions for over 2,000 years. Research trajectory: Silychristin differs from silybin in its second lignan unit — silybin is taxifolin + coniferyl alcohol; silychristin is taxifolin + sinapyl alcohol (which has an additional methoxy group). This structural difference gives silychristin distinct receptor binding and enzyme interaction profiles. Research has specifically characterised silychristin's RNA polymerase I (Pol I) stimulation — the enzyme responsible for ribosomal RNA synthesis and a rate-limiting step in hepatocyte protein synthesis and regeneration. Commercial source: Silychristin is co-delivered in Organic Milk Thistle Extract Powder and Milk Thistle Seed Liquid Extract from Herbuno, as part of the standardised silymarin complex.

---

Evidence for Silychristin Applications

Hepatoprotective activity: Silychristin demonstrates hepatoprotective activity in carbon tetrachloride (CCl₄) and galactosamine-induced liver injury models, reducing ALT, AST, and histological damage. Its potency as a single compound is somewhat lower than silybin in most assays, but it contributes to the synergistic hepatoprotection of the full silymarin complex — an important consideration for formulation decisions (whole silymarin versus isolated silybin). Claim strength: Moderate.

RNA polymerase I activation (hepatocyte regeneration): Silychristin specifically stimulates RNA polymerase I (Pol I) transcriptional activity in hepatocytes — increasing ribosomal RNA synthesis, protein synthesis capacity, and hepatocyte regeneration rate. This pro-regenerative mechanism is partially distinct from silybin's primary anti-hepatotoxic activity and suggests a complementary role: silybin for prevention of ongoing damage; silychristin for stimulation of repair. This is a mechanistic justification for using the full silymarin complex rather than isolated silybin in liver regeneration formulas. Claim strength: Moderate.

Antioxidant: Silychristin's taxifolin-derived catechol B-ring provides good radical scavenging activity, with Nrf2/HO-1 pathway induction in hepatocyte and neuronal models. DPPH and ABTS radical scavenging capacity is comparable to taxifolin and silybin. Claim strength: Moderate.

Anti-inflammatory: NF-κB inhibition and TNF-α/IL-6 suppression are documented for silychristin in macrophage activation models, consistent with the silymarin class broadly. COX-2 inhibition and iNOS suppression complement the hepatoprotective anti-inflammatory profile. Claim strength: Moderate.

---

Dosage & Formulator Specification

No isolated silychristin human dosing data exist. Silychristin is delivered as ~20% of standardised silymarin preparations. At the standard silymarin dose of 420 mg/day (140 mg three times daily), silychristin contributes approximately 84 mg/day. At higher hepatitis/NAFLD doses (600–1400 mg silymarin/day), silychristin delivery ranges from 120–280 mg/day.

For formulator specification: Organic Milk Thistle Extract Powder standardised to ≥70–80% silymarin delivers silychristin at 14–16% of total extract weight. The silymarin complex HPLC profile should confirm the characteristic silybin:silychristin:silydianin:isosilybin ratio (approximately 6:2:1:0.5) for authentic milk thistle quality verification. Adulterated or low-quality milk thistle extracts may show aberrant ratios.

Whether isolated silybin or full silymarin complex provides superior liver protection is a current research question. For regenerative applications (post-hepatic injury recovery, post-transplant liver support), the full silymarin complex including silychristin may be preferable to isolated silybin alone. For prevention of ongoing hepatocyte damage (NAFLD, alcoholic liver disease), silybin's superior antioxidant and membrane-stabilising activity may be primary.

Safety profile of silychristin is excellent — milk thistle extract is one of the best-tolerated botanical preparations in clinical use. No specific silychristin safety concerns beyond those of the full silymarin complex (mild GI effects at very high doses, rare allergic reactions in Asteraceae-sensitive individuals).

---

Frequently Asked Questions — Silychristin

How does silychristin differ structurally from silybin?
Both silybin and silychristin are flavonolignans formed from taxifolin condensed with a cinnamic alcohol via an ether bond. The difference lies in the second unit: silybin uses coniferyl alcohol (para-coumaryl alcohol with 4-hydroxy-3-methoxy cinnamyl structure); silychristin uses sinapyl alcohol (with an additional 5-methoxy group on the cinnamyl ring). This additional methoxy group in silychristin changes the lipophilicity, receptor binding geometry, and enzyme interactions — particularly the RNA polymerase I activation specificity that appears unique to silychristin.

What is RNA polymerase I and why is its stimulation by silychristin significant for liver health?
RNA polymerase I (Pol I) transcribes ribosomal RNA (rRNA) — the structural core of ribosomes. rRNA synthesis is the rate-limiting step in ribosome biogenesis, which determines the cell's protein synthesis capacity. Hepatocytes recovering from injury need to dramatically upregulate protein synthesis to repair damaged cellular structures. Silychristin's Pol I stimulation accelerates this repair process, providing a distinct pro-regenerative mechanism complementary to silybin's anti-injury protection.

Should formulators use whole silymarin or isolated silybin?
This decision depends on the application: for acute liver injury prevention (DILI, alcohol-associated hepatocyte damage), isolated silybin phospholipid complex (Siliphos®) provides superior bioavailability and concentrated antioxidant/membrane-stabilising activity. For post-injury regeneration and complex liver disease management (NAFLD, cirrhosis), whole silymarin preserving silychristin's Pol I-stimulating activity alongside silybin's protection provides mechanistically broader support. For general liver wellness and maintenance, standard silymarin extract (≥70% silymarin) delivering the full component spectrum at established clinical doses is the most evidence-based approach.

Is silychristin also present in artichoke extract (another liver herb)?
No — silychristin and the silymarin complex are unique to Silybum marianum (milk thistle). Artichoke (Cynara cardunculus) contains luteolin, chlorogenic acid, and cynarin as its primary active constituents — a completely different phytochemical profile with distinct (but overlapping in clinical use) hepatoprotective mechanisms. The two herbs are complementary: silymarin for antioxidant hepatocyte protection; artichoke for bile flow stimulation (choleretic) and cholesterol synthesis modulation via HMG-CoA reductase.

Related compounds: Silybin, Silydianin, Taxifolin, Ampelopsin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery